Sunshine Biopharma SBFM Q3 2025 earnings

FAQ

When did Sunshine Biopharma report Q3 2025 earnings?

Sunshine Biopharma (SBFM) reported Q3 2025 earnings on November 13, 2025 before market open.

What were Sunshine Biopharma's Q3 2025 revenue and EPS?

Sunshine Biopharma reported revenue of $9.4M and eps of $-0.19 for Q3 2025.

Did Sunshine Biopharma beat estimates in Q3 2025?

Revenue missed the consensus estimate of $11.1M by $1.7M. EPS missed the consensus estimate of $-0.13 by $0.06.

How did Sunshine Biopharma's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 11.6% from $8.4M a year earlier and eps grew 79.8% from $-0.94.

Where can I find Sunshine Biopharma's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0001683168-25-008328) directly on SEC EDGAR. The filing index links above go to sec.gov.